SynthesisClinical pharmacokinetics2023

A Model-Informed Approach to Accelerate the Clinical Development of Janagliflozin, an Innovative SGLT2 Inhibitor.

Ling Song et al.PubMed ↗Publisher ↗

No numbers read from the abstract.